Fudan-Zhangjiang (688505.SH) Stock Community - Hot Topic Discussions - Longbridge

Quote List Quote List

Event Tracking

Oct31

Fudan Zhangjiang Changes A-Share Raised Funds Purpose to Support Photodynamic Drug R&D

15:31

Oct30

Fudan-Zhangjiang released FY2025 Q3 earnings on October 30 After-Market (BJT), actual revenue CNY 160.99 M, actual EPS CNY -0.0828

01:00

Fudan-Zhangjiang released FY2025 9 Months Earnings on October 30 After-Market (BJT), Actual Revenue: CNY 551.08 M, Actual EPS: CNY -0.0773

01:00

Oct22

Fudan-Zhangjiang to Release FY2025 Q3 Earnings on October 30 After-Market BJT

02:35

Oct13

Affiliate of Fudan Zijang's Obeticholic Acid Tablets Application for Market Approval Rejected

10:04

Aug12

Fudan Zhangjiang Reports 91.89% Drop in Net Profit in H1 2025

10:52

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 160.99 M, Net Income -21.65 M, EPS -0.0828

Aug12

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 210.18 M, Net Income 3.05 M, EPS 0.0029

Apr28

Earning Release(CST)

FY2025 Q1 Earning Release (CNY) Revenue 179.91 M, Net Income 2.665 M, EPS 0.0025

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More